Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.68, $0.07 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $598.1 million versus the consensus estimate of $631.09 million.

GUIDANCE:

Globus Medical sees FY2025 EPS of $3.00-$3.30, versus the consensus of $3.40. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.73 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• JPMorgan Double Downgrades Gulfport Energy (GPOR) to Underweight
• Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
• Erste Group Downgrades AXA SA (CS:FP) (AXAHY) to Hold